Attached files

file filename
EX-4.5 - EXHIBIT 4.5 - ARGOS THERAPEUTICS INCexh_45.htm
EX-31.2 - EXHIBIT 31.2 - ARGOS THERAPEUTICS INCexh_312.htm
EX-31.1 - EXHIBIT 31.1 - ARGOS THERAPEUTICS INCexh_311.htm
EX-23.1 - EXHIBIT 23.1 - ARGOS THERAPEUTICS INCexh_231.htm
EX-10.44 - EXHIBIT 10.44 - ARGOS THERAPEUTICS INCexh_1044.htm
EX-10.40 - EXHIBIT 10.40 - ARGOS THERAPEUTICS INCexh_1040.htm
EX-10.28 - EXHIBIT 10.28 - ARGOS THERAPEUTICS INCexh_1028.htm
EX-4.3 - EXHIBIT 4.3 - ARGOS THERAPEUTICS INCexh_43.htm
10-K - FORM 10-K - ARGOS THERAPEUTICS INCf10k_031617p.htm

Exhibit 32.1

 

CERTIFICATIONS PURSUANT TO 18 U.S.C. 1350

 

The undersigned, the Chief Executive Officer and the Vice President of Finance (principal financial officer) of Argos Therapeutics, Inc. (the “Company”), each hereby certifies that, to his/her knowledge on the date hereof:

 

(a) the Annual Report on Form 10-K of the Company for the period ended December 31, 2016 filed on the date hereof with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

  By: /S/ JEFFREY D. ABBEY
    Jeffrey D. Abbey
    Chief Executive Officer
    March 16, 2017

 

  By: /S/ RICHARD D. KATZ, M.D.
   

Richard D. Katz, M.D.

Vice President and Chief Financial Officer

    March 16, 2017